Consult Dr A!

Dr. Anderson's answers clinical case questions!
21 Jun 2018

Hematologic Cancer Protocol

I have a patient with nodular regenerative hyperplasia secondary to high dose chemotherapy. He is a 31 year old white male s/p autologous stem cell transplant in March 2016, for recurrence of hodgekin’s lymphoma. The chemotherapies in which the patient has received include, busulfan, mephalan, zyracidonic acid, gemzar, nivolumab, brentuximab. Patient has elevated, alkphos, AST and ALT with slight elevation in bilirubin. There is no hepatospelenomegaly, but patient did have enlarged spleen which was likely related to lymphoma and or ITP which patient responded to IVIG. The main clinical question is, What protocol would be best for this patient?

Dr. Anderson:

This protocol is what I use with hematologic cancers.
You need all of it however to really work.
It can be oral or IV (for the Poly-DCA) and the DCA duses if IV we tend to ramp up to 30 mg/kg and not go higher.
I’m publishing an update to this in Townsend in September

To access Dr. Paul Anderson’s professional educational content, become a subscriber at My Account.

To consult Dr A about a case, please fill out the form at the Contact Portal.

For patient questions and concerns, refer to the clinic, Advanced Medical Therapies.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Dr. Anderson!

 

You'll receive a weekly recap of all of Dr. Anderson's Webinars, Speaking Engagement, Podcasts, Blog Posts, and more!

Plus, you'll also hear about upcoming events and news before anyone else!

Thanks for joining!

You'll receive a confirmation email shortly!